Consumers share health info via e-mail: survey

Share this article:
E-mail is the most popular form of social media among consumers sharing health info, data from a recent survey show.

Eighteen percent of consumer online health connectors used e-mail to share their personal
experiences and opinions about health issues, followed by support groups or boards and blogs, said Monique Levy, senior analyst with Jupiter Research.

Levy is lead researcher on Jupiter Research’s report, “Online Health: Assessing the Risk and Opportunity of Social and One-to-One Media.” The report presents insights about the online habits of 2,104 randomly selected US consumers from a survey conducted in November.

Levy said 13% of surveyed consumers read or posted a health-related message through a support board, compared with 21% of online users doing so for other reasons. Similarly, 10% of users read a health-related blog during the past year, while 23% read a blog for other reasons.

A majority of those surveyed, 66% said they used none of the aforementioned social media tools.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...